We attended the Annual Meeting of the European Society for Medical Oncology 2017 (ESMO 2017) from 8th to 12th September in Madrid.
More than 23’000 clinicians and researchers participated in the event providing insights and discussing controversial issues in the field. Cooperation between different disciplines such as oncologists, haematologists clinicians and clinical researchers will be key in the area of immunooncology (IO), where complexity is rapidly increasing.
The MSCI World Healthcare NR Index returned -2.7% in February, while the MSCI World NR Index rose 2.6%. During the last week of the month, many sectors took a hit because of rising 10-year Treasury rates (now at their highest levels in a year), enhancing on one hand the attractiveness of bonds vs. Equities and on the other hand propelling cyclical stocks.
Healthcare started 2021 on a very positive note, outperforming most of the other sectors (Energy, 3.0%, being the sole exception). The MSCI World Healthcare Net Return (NR) Index gained 1.1% in January 2021, while the MSCI World NR Index declined 1.0%.
The MSCI World Healthcare Net Return (NR) Index rose by 9.0% in November 2020 and the MSCI World NR Index gained 12.8%. November was the best month for global equities year-to-date (12.8%), with cyclicals outperforming defensive sectors.